194 related articles for article (PubMed ID: 9122179)
1. Sequence requirements of the HIV-1 protease flap region determined by saturation mutagenesis and kinetic analysis of flap mutants.
Shao W; Everitt L; Manchester M; Loeb DD; Hutchison CA; Swanstrom R
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2243-8. PubMed ID: 9122179
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of an in vivo HIV-1 protease mutant in complex with saquinavir: insights into the mechanisms of drug resistance.
Hong L; Zhang XC; Hartsuck JA; Tang J
Protein Sci; 2000 Oct; 9(10):1898-904. PubMed ID: 11106162
[TBL] [Abstract][Full Text] [Related]
3. Curling of flap tips in HIV-1 protease as a mechanism for substrate entry and tolerance of drug resistance.
Scott WR; Schiffer CA
Structure; 2000 Dec; 8(12):1259-65. PubMed ID: 11188690
[TBL] [Abstract][Full Text] [Related]
4. Ninety-nine is not enough: molecular characterization of inhibitor-resistant human immunodeficiency virus type 1 protease mutants with insertions in the flap region.
Kozísek M; Sasková KG; Rezácová P; Brynda J; van Maarseveen NM; De Jong D; Boucher CA; Kagan RM; Nijhuis M; Konvalinka J
J Virol; 2008 Jun; 82(12):5869-78. PubMed ID: 18400858
[TBL] [Abstract][Full Text] [Related]
5. Kinetic and modeling studies of subsites S4-S3' of Moloney murine leukemia virus protease.
Menéndez-Arias L; Weber IT; Soss J; Harrison RW; Gotte D; Oroszlan S
J Biol Chem; 1994 Jun; 269(24):16795-801. PubMed ID: 8207003
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for distinctions between substrate and inhibitor specificities for feline immunodeficiency virus and human immunodeficiency virus proteases.
Lin YC; Beck Z; Morris GM; Olson AJ; Elder JH
J Virol; 2003 Jun; 77(12):6589-600. PubMed ID: 12767979
[TBL] [Abstract][Full Text] [Related]
7. In vitro selection and characterization of human immunodeficiency virus type 1 (HIV-1) isolates with reduced sensitivity to hydroxyethylamino sulfonamide inhibitors of HIV-1 aspartyl protease.
Partaledis JA; Yamaguchi K; Tisdale M; Blair EE; Falcione C; Maschera B; Myers RE; Pazhanisamy S; Futer O; Cullinan AB
J Virol; 1995 Sep; 69(9):5228-35. PubMed ID: 7636964
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of the sequences and structures of HIV-1 and HIV-2 proteases.
Gustchina A; Weber IT
Proteins; 1991; 10(4):325-39. PubMed ID: 1946342
[TBL] [Abstract][Full Text] [Related]
9. Flap opening in HIV-1 protease simulated by 'activated' molecular dynamics.
Collins JR; Burt SK; Erickson JW
Nat Struct Biol; 1995 Apr; 2(4):334-8. PubMed ID: 7796268
[TBL] [Abstract][Full Text] [Related]
10. Analysis of substrate interactions of the Rous sarcoma virus wild type and mutant proteases and human immunodeficiency virus-1 protease using a set of systematically altered peptide substrates.
Grinde B; Cameron CE; Leis J; Weber IT; Wlodawer A; Burstein H; Skalka AM
J Biol Chem; 1992 May; 267(14):9491-8. PubMed ID: 1315756
[TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of the substrate binding pocket of murine leukemia virus protease and comparison with human immunodeficiency virus proteases.
Menéndez-Arias L; Weber IT; Oroszlan S
J Biol Chem; 1995 Dec; 270(49):29162-8. PubMed ID: 7493942
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of human immunodeficiency virus (HIV) type 2 protease in complex with a reduced amide inhibitor and comparison with HIV-1 protease structures.
Tong L; Pav S; Pargellis C; Dô F; Lamarre D; Anderson PC
Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8387-91. PubMed ID: 8378311
[TBL] [Abstract][Full Text] [Related]
13. Proteolysis of an active site peptide of lactate dehydrogenase by human immunodeficiency virus type 1 protease.
Tomaszek TA; Moore ML; Strickler JE; Sanchez RL; Dixon JS; Metcalf BW; Hassell A; Dreyer GB; Brooks I; Debouck C
Biochemistry; 1992 Oct; 31(42):10153-68. PubMed ID: 1420138
[TBL] [Abstract][Full Text] [Related]
14. Systematic mutational analysis of the active-site threonine of HIV-1 proteinase: rethinking the "fireman's grip" hypothesis.
Strisovsky K; Tessmer U; Langner J; Konvalinka J; Kräusslich HG
Protein Sci; 2000 Sep; 9(9):1631-41. PubMed ID: 11045610
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of the substrate binding pockets of the Rous sarcoma virus and human immunodeficiency virus-1 proteases.
Cameron CE; Ridky TW; Shulenin S; Leis J; Weber IT; Copeland T; Wlodawer A; Burstein H; Bizub-Bender D; Skalka AM
J Biol Chem; 1994 Apr; 269(15):11170-7. PubMed ID: 8157644
[TBL] [Abstract][Full Text] [Related]
16. Activity of tethered human immunodeficiency virus 1 protease containing mutations in the flap region of one subunit.
Tözsér J; Yin FH; Cheng YS; Bagossi P; Weber IT; Harrison RW; Oroszlan S
Eur J Biochem; 1997 Feb; 244(1):235-41. PubMed ID: 9063469
[TBL] [Abstract][Full Text] [Related]
17. Crystallographic analysis of human immunodeficiency virus 1 protease with an analog of the conserved CA-p2 substrate -- interactions with frequently occurring glutamic acid residue at P2' position of substrates.
Weber IT; Wu J; Adomat J; Harrison RW; Kimmel AR; Wondrak EM; Louis JM
Eur J Biochem; 1997 Oct; 249(2):523-30. PubMed ID: 9370363
[TBL] [Abstract][Full Text] [Related]
18. Site-directed mutagenesis of HIV-1 protease: generation of mutant proteases with increased stability to autodigestion.
Tomasselli AG; Mildner AM; Rothrock DJ; Sarcich JL; Lull J; Leone J; Heinrikson R
Adv Exp Med Biol; 1995; 362():473-7. PubMed ID: 8540360
[No Abstract] [Full Text] [Related]
19. Inhibitor binding to the Phe53Trp mutant of HIV-1 protease promotes conformational changes detectable by spectrofluorometry.
Rodríguez EJ; Debouck C; Deckman IC; Abu-Soud H; Raushel FM; Meek TD
Biochemistry; 1993 Apr; 32(14):3557-63. PubMed ID: 8466899
[TBL] [Abstract][Full Text] [Related]
20. A side chain at position 48 of the human immunodeficiency virus type-1 protease flap provides an additional specificity determinant.
Moody MD; Pettit SC; Shao W; Everitt L; Loeb DD; Hutchison CA; Swanstrom R
Virology; 1995 Mar; 207(2):475-85. PubMed ID: 7886951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]